CRISPR Market by Product Type (Plasmids, Vectors, CAS9 Nuclease & GRNA, Delivery System), Application (Genetic Engineering, Cell Engineering) & End User (Biotechnology & Pharmaceutical Companies, Contract Research Organization) - Global Forecast to 2023

Report Code: UC 1937 Jan, 2019, by

The global CRISPR market is expected to reach USD 4.16 billion by 2023 from USD 2.01 billion in 2018, growing at a CAGR of 15.7%. Increasing incidences and prevalence of genetic disorders, rising government funding on genomic research, increasing production of genetically modified crops and increasing demand for drug discovery are some of the major factors driving the growth of the global CRISPR market.

North America dominates the CRISPR market with the North America accounted major market share in 2017. The development of gene therapy, increasing use of genetically modified (GM) crops, and rising availability of research grants and funding for genomic projects are some of the major driving factors driving the growth of this market in North America. The Asia-Pacific CRISPR market is poised to grow at the highest CAGR during the forecast period. The increasing incidences of generic disorder, rising funding on genomic research and increasing funding on genomic research are major driving factors for this market. Furthermore, emerging countries such as India and China provides immense growth opportunities to the CRISPR manufacturers.

Prominent players in the CRISPR market are Thermofisher Scientific (US), Lonza (Switzerland), Merck (Germany), Horizon Discovery Group (UK), CRISPR Therapeutics (Switzerland), Addgene (US), Editas Medicine (US) , Origene Technologies (US), Sangamo Biosciences Inc. (US) and GENSCRIPT (US)

Scope of the Report

This research report covers the global CRISPR market by method; product type; application; end user; and geography.

CRISPR Market, by Product Type

  • Design Tools
  • Plasmids And Vectors
  • Cas9 Nuclease And GRNA
  • Delivery System

CRISPR Market, BY Application

  • Genetic Engineering
    1. Plant Genetic Engineering
    2. Animal Genetic Engineering
  • Cell Line Engineering
  • GRNA Database/Gene Library
  • Others (If Any)

CRISPR Market, by End User

  • Biotechnology and Pharmaceutical Companies
  • Research and Academic Institutes
  • Contract Research Organizations
  • Others (If Any)

CRISPR Market, BY Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World (RoW)

Table of Contents

1 Introduction
    1.1 Objective of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered in the Study
    1.4 Stakeholders

2 Research Methodology
    2.1 Market Size Estimation
    2.2 Market Crackdown and Data Triangulation
    2.3 Market Share Estimation
           2.3.1 Key Data Points Taken From Secondary Sources
           2.3.2 Key Data Points Taken From Primary Sources
    2.4 Assumptions

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
           5.2.2 Restraints
           5.2.3 Opportunities
           5.2.4 Challenges

6 CRISPR Market, By Product Type
    6.1 Introduction
    6.2 Design Tools
    6.3 Plasmids and Vectors
    6.3 Cas9 Nuclease and Grna
    6.3 Delivery System

7 CRISPR Market, By Application
    7.1 Introduction
    7.2 Genetic Engineering 
           7.2.1 Plant Genetic Engineering
           7.2.2 Animal Genetic Engineering
    7.3 Cell Line Engineering 
    7.4 Grna Database/Gene Library
    7.5 Others (If Any)

8 CRISPR Market, By End User
    8.1 Introduction
    8.2 Biotechnology and Pharmaceutical Companies
    8.3 Research and Academic Institutes
    8.4 Contract Research Organizations
    8.5 Others (If Any)

9 CRISPR Market, By Region
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 UK
           9.3.3 France
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 Rest of Europe (RoE)
    9.4 Asia Pacific
           9.4.1 China
           9.4.2 India
           9.4.3 Japan
           9.4.4 Rest of Asia Pacific
    9.5 Rest of the World (RoW)

10 Competitive Landscape
     10.1 Introduction
     10.2 Market Share Analysis
     10.3 Competitive Situation and Trends

11 Company Profiles*
     11.1 Introduction
     11.2 Thermo Fisher Scientific
             11.2.1 Business Overview
             11.2.2 Company Snapshot
             11.2.3 Products and Services
             11.2.4 Recent Developments
             11.2.5 MnM View
     11.3 Horizon Discovery Group 
     11.4 Lonza 
     11.5 Genscript
     11.6 Addgene
     11.7 Merck 
     11.8 CRISPR Therapeutics AG 
     11.9 Editas Medicine
     11.10 Origene Technologies 
     11.11 Sangamo Biosciences Inc.

Note: *Details on Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.
* 10 Market Leaders Will Be Profiled
* Segmentation May Change During the Planned Research Work

Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
UC 1937
Published ON
Jan, 2019
Choose License Type
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the CRISPR Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
© MarketsandMarkets Research Private Ltd. All rights reserved